Table 2. Variants of uncertain significance in known PCD genes through CNV and WES analysis.
Family | Patient | Ethnicity | Sex | Age at Dx | Situs Status | Ciliary EM | nNO nL/min | Gene | hg 19 Genomic coordinates | Transcript | Exon/ Intron | Base Changes | Predicted Effect | Segregation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound heterozygous, likely pathogenic (solved) | ||||||||||||||
114 | 9 | White | M | 4 yr | S | ODA+IDAa | 13.4 | DYX1C1 | Chr15: 55727162 | NM_130810.3 | Ex 8 | c.988C > T | p.R330W | Maternal |
DYX1C1 | Chr15: 55729606- | NM_130810.3 | Int 7 | Ex 7 2.1Kb del (6) | Paternal | |||||||||
55731727 | Ex 7 | |||||||||||||
132 | 21 | White | M | 6 yr | I | Normal | 4.9 | DNAH11 | Chr7: 21847620 | NM_001277115.1 | Ex 63 | c.10285C > A | p.R3429S | Unknown |
DNAH11 | Chr7: 21604615- | NM_001277115.1 | Int 6 | Ex7-14 32.29Kb dup | Unknown | |||||||||
21636907 | Int 14 | |||||||||||||
Homozygous VUS | ||||||||||||||
142 | 51 | Sri Lankan Tamil | F | 18 yr | S | Inconclusive | 14.5 | DNAH11 | Chr7: 21639487 | NM_001277115.1 | Ex 15 | c.2750A > T | p.E917V | Unknown |
DNAH11 | Chr7: 21847621 | NM_001277115.1 | Ex 63 | c.10286G > T | p.R3429L | Unknown | ||||||||
136 | 44 | Portuguese | M | 8 yr | S | Normal | 20.1 | DNAAF3 | Chr19: 55670702 | NM_001256714.1 | Ex 12 | c.1555G > C | p.A519P | Unknown |
Single VUS | ||||||||||||||
134 | 38 | Hispanic | M | 15 yr | S | Normal | 17 | DNAH11 | Chr7: 21940666 | NM_001277115.1 | Ex 82 | c.13345C > T | p.R4449C | Unknown |
Genomic coordinates are approximate for copy number variations. Further clinical characteristics previously described (Kim et al. 2014). Previously described mutations are in bold (6) (Tarkar et al. 2013). Cases with two VUS, likely pathogenic were considered solved cases. PCD, primary ciliary dyskinesia; CNV, copy number variation; WES, whole-exome sequencing; Dx, diagnosis; EM, electron microscopy; M, male; S, situs solitus; I, situs inversus; ODA, outer dynein arms, IDA inner dynein arms; F, female; inconclusive = adequate sample inconclusive EM.
Revised after pathology review.